Product Information
RIZATRIPTAN 5 MG ODT is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.5086 per EA under NDC 33342009341. Its NADAC has been published 390 times since Jan 9, 2019.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342009341
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA203146On Market Since
9/23/2014
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG ODT has been published 390 times since Jan 9, 2019, and over the history we have for it it has declined 47.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5086 per EA |
|---|---|
| All-time high | $1.3658 (Dec 16, 2020) |
| All-time low | $0.4078 (Jul 17, 2024) |
| 52-week high | $0.5974 |
| 52-week low | $0.4842 |
| Median price | $0.7558 |
| Average price | $0.8073 |
| Largest weekly change | +69.8% (Aug 21, 2024) |
| Weeks tracked | 390 |
| Tracking since | Jan 9, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG ODT, manufactured by Macleods Pharmaceuticals Limited, is $0.5086 per EA (NDC 33342009341), effective Jun 24, 2026.
How has the price of RIZATRIPTAN 5 MG ODT changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG ODT has declined 47.4%. It has been tracked across 390 weekly CMS publications since Jan 9, 2019.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG ODT?
Since Jan 9, 2019, the NADAC for RIZATRIPTAN 5 MG ODT has ranged from a low of $0.4078 (Jul 17, 2024) to a high of $1.3658 (Dec 16, 2020), with a median of $0.7558 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG ODT?
3 NADAC-published products share the same active ingredient, strength, and dosage form as RIZATRIPTAN 5 MG ODT, but none are currently priced below it.
Who manufactures RIZATRIPTAN 5 MG ODT?
RIZATRIPTAN 5 MG ODT (NDC 33342009341) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification